Rocket Pharmaceuticals to Present at 41st Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 01/03/23
Rocket Pharmaceuticals Provides Update on Anticipated Registration Path for RP-A501 in Danon Disease Following End-of-Phase 1 FDA MeetingBusiness Wire • 12/22/22
Rocket Pharmaceuticals Presents Positive Clinical Data from Fanconi Anemia, Pyruvate Kinase Deficiency and Severe Leukocyte Adhesion Deficiency-I Programs at the 64th American Society of Hematology (ASH) Annual MeetingBusiness Wire • 12/12/22
Rocket Pharmaceuticals to Present at the 5th Annual Evercore ISI HealthCONx ConferenceBusiness Wire • 11/21/22
RENOVACOR INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Renovacor, Inc. - RCORPRNewsWire • 11/03/22
Rocket Pharmaceuticals Reports Third Quarter 2022 Financial Results and Highlights Recent ProgressBusiness Wire • 11/03/22
Rocket Pharmaceuticals Announces Presentations Highlighting AAV and Lentiviral Gene Therapies at Upcoming Scientific CongressesBusiness Wire • 11/03/22
Wall Street Analysts See an 184% Upside in Rocket Pharmaceuticals (RCKT): Can the Stock Really Move This High?Zacks Investment Research • 10/27/22
Rocket Pharmaceuticals Announces Presentations Highlighting Lentiviral Gene Therapies at the 29th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)Business Wire • 10/12/22
Does Rocket Pharmaceuticals (RCKT) Have the Potential to Rally 212% as Wall Street Analysts Expect?Zacks Investment Research • 10/11/22
Rocket Pharmaceuticals to Present at the 2022 Cell & Gene Meeting on the MesaBusiness Wire • 10/10/22
Rocket Pharmaceuticals Announces Positive Updates from Phase 1 Clinical Trial for RP-A501 in Danon Disease at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2022Business Wire • 09/30/22
Rocket Pharmaceuticals to Present at Chardan 6th Annual Genetic Medicines ConferenceBusiness Wire • 09/27/22
RCKT STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Merger of Rocket Pharmaceuticals, Inc. Is Fair to ShareholdersBusiness Wire • 09/20/22
Rocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-based Cardiac Gene TherapyBusiness Wire • 09/20/22
Rocket Pharmaceuticals to Present Updated Data from Phase 1 Danon Disease Trial for RP-A501 at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2022Business Wire • 09/16/22
Rocket Pharmaceuticals to Present at Morgan Stanley 20th Annual Global Healthcare ConferenceBusiness Wire • 09/06/22
Rocket Pharmaceuticals: Updates To Thesis, Clinical Momentum Continues To AccelerateSeeking Alpha • 08/25/22